1-10 of 10
Sofia D. Merajver
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A009: Integrative drug screening and multi-omic characterization of patient-derived bladder cancer organoids reveals novel molecular correlates of chemotherapy response

Nathan M. Merrill, Samuel D. Kaffenberger, Liwei Bao, Nathalie Vandecan, Laura E. Goo, Athena Apfel, Xu Cheng, Zhaoping Qin, Chia-Jen Liu, Armand Bankhead, Yin Wang, Varun Kathawate, Lila Tudrick, Habib Serhan, Zackariah Farah, Chad Ellimoottil, Khaled S. Hafez, Lindsey A. Herrel, Jeffrey S. Montgomery, Todd M. Morgan, Simpa S. Salami, Alon Z. Weizer, Peter J. Ulintz, Mark L. Day, Matthew B. Soellner, Phillip L. Palmbos, Sofia D. Merajver, Aaron M. Udager
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10_Supplement): A009.
https://doi.org/10.1158/1557-3265.BLADDER24-A009
Published: 17 May 2024
View article titled, Abstract A009: Integrative drug screening and multi-omic characterization of patient-derived bladder cancer organoids reveals novel molecular correlates of chemotherapy response
Journal Articles

A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer

Smita Bhatia, Melanie R. Palomares, Lindsey Hageman, Yanjun Chen, Wendy Landier, Kandice Smith, Heidi Umphrey, Caroline A. Reich, Kathryn W. Zamora, Saro H. Armenian, Therese B. Bevers, Anne Blaes, Tara Henderson, David Hodgson, Melissa M. Hudson, Larissa A. Korde, Susan A. Melin, Sofia D. Merajver, Linda Overholser, Sandhya Pruthi, F. Lennie Wong, Judy E. Garber
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (4): 967–974.
https://doi.org/10.1158/1078-0432.CCR-20-3609
Published: 15 February 2021
View article titled, A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer
Open the PDF for A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 38: Molecular determinants of drug response in TNBC cell lines

Nathan M. Merrill, Eric J. Lachacz, Nathalie M. Vandecan, Peter J. Ulintz, Li Wei Bao, John P. Lloyd, Aki Morikawa, Sofia D. Merajver, Matthew B. Soellner
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_1): 38.
https://doi.org/10.1158/1557-3265.ADVPRECMED20-38
Published: 15 June 2020
View article titled, Abstract 38: Molecular determinants of drug response in TNBC cell lines
Journal Articles

Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Rabia A. Gilani, Sameer Phadke, Li Wei Bao, Eric J. Lachacz, Michele L. Dziubinski, Kristoffer R. Brandvold, Michael E. Steffey, Frank E. Kwarcinski, Carrie R. Graveel, Kelley M. Kidwell, Sofia D. Merajver, Matthew B. Soellner
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (7): 1777.
https://doi.org/10.1158/1078-0432.CCR-20-0653
Published: 01 April 2020
View article titled, Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer
Open the PDF for Retraction: UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer in another window
Journal Articles

UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Rabia A. Gilani, Sameer Phadke, Li Wei Bao, Eric J. Lachacz, Michele L. Dziubinski, Kristoffer R. Brandvold, Michael E. Steffey, Frank E. Kwarcinski, Carrie R. Graveel, Kelley M. Kidwell, Sofia D. Merajver, Matthew B. Soellner
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (20): 5087–5096.
https://doi.org/10.1158/1078-0432.CCR-15-2158
Published: 13 October 2016
View article titled, UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer
Open the PDF for UM-164: A Potent c-Src/p38 Kinase Inhibitor with <em>In Vivo</em> Activity against Triple-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Antiangiogenic Tetrathiomolybdate Protects against Her2/neu-Induced Breast Carcinoma by Hypoplastic Remodeling of the Mammary Gland

Quintin Pan, Devin T. Rosenthal, Liwei Bao, Celina G. Kleer, Sofia D. Merajver
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7441–7446.
https://doi.org/10.1158/1078-0432.CCR-09-1361
Published: 30 November 2009
View article titled, Antiangiogenic Tetrathiomolybdate Protects against Her2/neu-Induced Breast Carcinoma by Hypoplastic Remodeling of the Mammary Gland
Open the PDF for Antiangiogenic Tetrathiomolybdate Protects against Her2/neu-Induced Breast Carcinoma by Hypoplastic Remodeling of the Mammary Gland in another window
Journal Articles

RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck

Celina G. Kleer, Theodoros N. Teknos, Mozaffarul Islam, Benjamin Marcus, Julia Shin-Jung Lee, Quintin Pan, Sofia D. Merajver
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (15): 4485–4490.
https://doi.org/10.1158/1078-0432.CCR-06-0376
Published: 09 August 2006
View article titled, RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck
Open the PDF for RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck in another window
Journal Articles

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer

Bruce G. Redman, Peg Esper, Quintin Pan, Rodney L. Dunn, Hero K. Hussain, Thomas Chenevert, George J. Brewer, Sofia D. Merajver
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (5): 1666–1672.
Published: 01 May 2003
View article titled, Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer
Open the PDF for Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer in another window
Journal Articles

Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study

George J. Brewer, Robert D. Dick, Damanjit K. Grover, Virginia LeClaire, Michael Tseng, Max Wicha, Kenneth Pienta, Bruce G. Redman, Thierry Jahan, Vernon K. Sondak, Myla Strawderman, Gerald LeCarpentier, Sofia D. Merajver
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (1): 1–10.
Published: 01 January 2000
View article titled, Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study
Open the PDF for Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study in another window
Journal Articles

A Novel Putative Low-Affinity Insulin-like Growth Factor-binding Protein, LIBC (Lost in Inflammatory Breast Cancer), and RhoC GTPase Correlate with the Inflammatory Breast Cancer Phenotype

Kenneth L. van Golen, Seena Davies, Zhi Fen Wu, YunFang Wang, Corazon D. Bucana, Holly Root, Settara Chandrasekharappa, Myla Strawderman, Stephen P. Ethier, Sofia D. Merajver
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2511–2519.
Published: 01 September 1999
View article titled, A Novel Putative Low-Affinity Insulin-like Growth Factor-binding Protein, LIBC (Lost in Inflammatory Breast Cancer), and RhoC GTPase Correlate with the Inflammatory Breast Cancer Phenotype
Open the PDF for A Novel Putative Low-Affinity Insulin-like Growth Factor-binding Protein, LIBC (Lost in Inflammatory Breast Cancer), and RhoC GTPase Correlate with the Inflammatory Breast Cancer Phenotype in another window